Evidence map›Paper›PMID 27014033›Full record

ArticleFrontiers in human neuroscience2016

A Diamond-Based Electrode for Detection of Neurochemicals in the Human Brain.

Kevin E Bennet, Jonathan R Tomshine, Hoon-Ki Min, Felicia S Manciu, Michael P Marsh, Seungleal B Paek, Megan L Settell, Evan N Nicolai, Charles D Blaha, Abbas Z Kouzani and 2 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in human neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01705301 (Neurotransmitter Measurements Using Wireless Instantaneous Neurotransmitter Concentration System), which is not on this map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01705301 completednot on this map

Neurotransmitter Measurements Using Wireless Instantaneous Neurotransmitter Concentration System (WINCS) During Deep Brain Stimulation Neurosurgery.

TypeobservationalSponsorMayo ClinicRan2010 to 2017Enrolled36ConditionsEssential Tremor, Parkinson's Disease, DystoniaArmsWINCS
3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 102 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Improved longevity andFrontiers in bioengineering and biotechnology · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. The Analyst · 2022
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Kevin E BennetDivision of Engineering, Mayo ClinicRochester, MN, USA; Neurologic Surgery, Mayo ClinicRochester, MN, USA; School of Engineering, Deakin UniversityMelbourne, VIC, Australia.
Jonathan R TomshineDivision of Engineering, Mayo ClinicRochester, MN, USA; Neurologic Surgery, Mayo ClinicRochester, MN, USA.
Hoon-Ki MinNeurologic Surgery, Mayo Clinic Rochester, MN, USA.
Felicia S ManciuPhysics, University of Texas at El Paso El Paso, TX, USA.
Michael P MarshNeurologic Surgery, Mayo Clinic Rochester, MN, USA.
Seungleal B PaekNeurologic Surgery, Mayo Clinic Rochester, MN, USA.
Megan L SettellNeurologic Surgery, Mayo Clinic Rochester, MN, USA.
Evan N NicolaiNeurologic Surgery, Mayo Clinic Rochester, MN, USA.
Charles D BlahaNeurologic Surgery, Mayo Clinic Rochester, MN, USA.
Abbas Z KouzaniSchool of Engineering, Deakin University Melbourne, VIC, Australia.
Su-Youne ChangNeurologic Surgery, Mayo Clinic Rochester, MN, USA.
Kendall H LeeNeurologic Surgery, Mayo Clinic Rochester, MN, USA.
WinnMed · USMayo Clinic · USDeakin University · AUThe University of Texas at El Paso · US

Funding

Neurotransmitter Absolute Concentration Determination with Diamond ElectrodeU01NS090455 · NINDS · MAYO CLINIC ROCHESTER · PI LEE, KENDALL H., MANCIU, FELICIA S. · 2014 to 2016
$2.4M
WINCS and DBSR01NS070872 · NINDS · MAYO CLINIC ROCHESTER · PI LEE, KENDALL H. · 2011 to 2015
$1.7M
WincsNanotrode development for DBSR01NS075013 · NINDS · MAYO CLINIC ROCHESTER · PI LEE, KENDALL H. · 2011 to 2015
$1.6M
NINDS NIH HHS R01 NS070872NINDS NIH HHS R01 NS075013NINDS NIH HHS U01 NS090455
6 · The paper itself

Abstract

Deep brain stimulation (DBS), a surgical technique to treat certain neurologic and psychiatric conditions, relies on pre-determined stimulation parameters in an open-loop configuration. The major advancement in DBS devices is a closed-loop system that uses neurophysiologic feedback to dynamically adjust stimulation frequency and amplitude. Stimulation-driven neurochemical release can be measured by fast-scan cyclic voltammetry (FSCV), but existing FSCV electrodes rely on carbon fiber, which degrades quickly during use and is therefore unsuitable for chronic neurochemical recording. To address this issue, we developed durable, synthetic boron-doped diamond-based electrodes capable of measuring neurochemical release in humans. Compared to carbon fiber electrodes, they were more than two orders-of-magnitude more physically-robust and demonstrated longevity in vitro without deterioration. Applied for the first time in humans, diamond electrode recordings from thalamic targets in patients (n = 4) undergoing DBS for tremor produced signals consistent with adenosine release at a sensitivity comparable to carbon fiber electrodes. (Clinical trials # NCT01705301).

Indexed as

carbon fiber microelectrodedeep brain stimulation (DBS)diamond-based electrodedopaminefast scan cyclic voltammetry (FSCV)neuromodulation

Identifiers

PMID27014033
PMCPMC4791376
OpenAlexW2317519131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.